Phytoestrogens: A Review of Recent Findings
- 1 January 2002
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 15 (5), 561-572
- https://doi.org/10.1515/jpem.2002.15.5.561
Abstract
Phytoestrogens have been investigated at the epidemiological, clinical and molecular levels to determine their potential health benefits. The two major groups of phytoestrogens, isoflavones and lignans, are abundant in soy products and flax respectively, but are also present in a variety of other foods. It is thought that these estrogen-like compounds may protect against chronic diseases, such as hormone-dependent cancers, cardiovascular disease and osteoporosis. Furthermore, phytoestrogens are used as a natural alternative to hormone replacement therapy and to reduce menopausal symptoms. Phytoestrogens have been shown to induce both estrogenic and anti-estrogenic effects but their biological relevance and potency have not been well characterized. In children, consumption of soy-based formulas and soy milk can lead to high levels of exposure to phytoestrogens with only limited data available concerning potential benefits or adverse effects. Phytoestrogens are considered good candidates for use in natural therapies and as chemopreventive agents in adults. Safe and efficacious levels have yet to be established.Keywords
This publication has 66 references indexed in Scilit:
- Phytoestrogen supplementation and endometrial cancerPublished by Wolters Kluwer Health ,2004
- Dietary Soy Has Both Beneficial and Potentially Adverse Cardiovascular Effects: A Placebo-Controlled Study in Men and Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2001
- Role of oxygen free radicals in cancer developmentEuropean Journal Of Cancer, 1996
- Commentary: The Structural Pervasiveness of Estrogenic ActivityEnvironmental Health Perspectives, 1995
- Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal womenJournal of Clinical Endocrinology & Metabolism, 1995
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- The tyrosine kinase inhibitors methyl 2,5‐dihydroxycinnamate and genistein reduce thrombin‐evoked tyrosine phosphorylation and Ca2+ entry in human plateletsFEBS Letters, 1993
- Mammalian lignan production from various foodsNutrition and Cancer, 1991
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Production and metabolism of lignans by the human faecal floraJournal of Applied Bacteriology, 1985